G
1707
vs
T
Taiwan Weighted Index
Over the past 12 months, Grape King Bio Ltd has underperformed Taiwan Weighted Index, delivering a return of -18% compared to the Taiwan Weighted Index's +43% growth.
Stocks Performance
1707 vs Taiwan Weighted Index
Performance Gap
1707 vs Taiwan Weighted Index
Performance By Year
1707 vs Taiwan Weighted Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Grape King Bio Ltd
Glance View
Grape King Bio Ltd. engages in the production and sale of pharmaceutical preparations, patent medicine, liquid tonics, drinks, and healthy food. The company is headquartered in Taoyuan, Taoyuan. The firm operates through three business segments. The Direct Sales segment is engaged in the development and manufacture of related products for subsidiaries. The Distribution segment is engaged in the provision of own-brand products. The Original Equipment Manufacturer (OEM) segment is engaged in the OEM business in Taiwan and Shanghai. The main products include lactic acid bacteria products and other healthcare products, as well as beverage products, medicines and cosmetics. The firm operates in Taiwan, mainland China and other markets.
